Opportunity & Inclusion Environmental Sustainability Pro Bono

About Us

Awards & Accolades

Locations

North America

Washington, D.C.

Asia

Europe

Middle East

What We Do
Who We Are
Insights
Join Us

Subscribe

Follow us

Search

Jump to

Who We Are (1092)What We Do (270)Insights (15594)More Results (64)

Most Relevant

Who We Are

Associate

+1 212.872.8199

Associate

+971 4.317.3052

Associate

+1 202.887.4171

Senior Advisor

+1 202.887.4151

Associate

+1 202.887.4056

Angela Denise Adams

Senior Counsel

+1 202.887.4523

Jordan M. Adams

Associate

+1 212.872.7431

Christopher Adinolfi

Associate

+1 212.872.8130

View All Who We Are

What We Do

Complex Commercial Litigation

Complex Commercial Litigation

Administrative & Regulatory Litigation

Region

Region

Sectors

Sectors

AgTech & FoodTech

American Indian Policy & Regulation

American Indian Policy & Regulation

American Indian Gaming & Compact Negotiation

Services

Services

American Indian Policy & Regulation

Services

Services

Anti-Money Laundering

Services

Services

Antibribery/Foreign Corrupt Practices Act (FCPA)

Services

Services

Antitrust & International Competition

Insights

Publications | Alerts

Publications | Alerts

September 26, 2025

CARB Publishes Preliminary List of Companies Potentially Subject to SB 253 and SB 261

Blog | Trump Executive Order Tracker

Blog | Trump Executive Order Tracker

September 26, 2025

Countering Domestic Terrorism and Organized Political Violence (Trump EO Tracker)

Publications | Alerts

Publications | Alerts

September 26, 2025

DHS Proposes Significant Changes to H-1B Visa Lottery

Blog | Trump Executive Order Tracker

Blog | Trump Executive Order Tracker

September 26, 2025

Executive Order Title Enforcing the Death Penalty Laws in the District of Columbia to Deter and Punish the Most Heinous Crimes (Trump EO Tracker)

Awards & Accolades

Awards & Accolades

September 25, 2025

Akin Named Finalist for International Law Firm of the Year and Two Additional Categories at the 2025 British Legal Awards

Blog | IP Newsflash

Blog | IP Newsflash

September 25, 2025

Federal Circuit: The Term 'Clinically Proven Effective' Amount Does Not Impart Patentability Over Prior Art for Claims That Also Recite Specific Numerical Dosages

Blog | OverRuled - Sanctions & Export Controls Updates

Blog | OverRuled - Sanctions & Export Controls Updates

2025-09-25

New Updates for 25-Sep-2025

Blog | Eye on FDA

Blog | Eye on FDA

September 24, 2025

FDA’s Latest on Emergency Diagnostics and a No-Frills Rescission of the LDT Rule

View All Insights

More Results

Client Stories

Client Stories

A Runway for the Fashion Industry

Site Content

Site Content

Location

Location

Site Content

Site Content

Agency Transparency in Merger Enforcement (TIME) Report

Site Content

Site Content

AI Law & Regulation Tracker

Site Content

Site Content

Site Content

Site Content

Akin’s 2025 Perspectives in Private Equity

Site Content

Site Content

Answering an Entertainment SOS